NCT06567431 · RECRUITING
Blood And Tears in Alzheimer's Disease
This study is testing whether Alzheimer's biomarkers show up in tear fluid and dried blood spots — basically, can a tear sample or a simple finger-prick blood card detect what a spinal tap already shows? It is an observational study with no phase designation, meaning it is exploratory research aimed at validating easier, less invasive ways to detect disease markers, not testing a treatment.
Eligibility criteria
Inclusion Criteria: Inclusion criteria for patients: * Lumbar puncture with CSF avaiable for analysis * Diagnosis of Alzheimer's disease, Dementia with Lewy Bodies (DLB), Frontotemporal dementia (FTD), vascular dementia (VaD) or Normal pressure hydrocephalus (NPH) * Of legal age. Inclusion criteria for controls: * Lumbar puncture with CSF avaiable for analysis * No neurological disease. * Of legal age. Exclusion Criteria: * No lumbar puncture * Clinically assessed as unfit to participate in the project.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-08-22